Search results
Results from the WOW.Com Content Network
Natamycin, also known as pimaricin, is an antifungal medication used to treat fungal infections around the eye. [1] [2] This includes infections of the eyelids, conjunctiva, and cornea. [1] It is used as eyedrops. [1] Natamycin is also used in the food industry as a preservative. [2] Allergic reactions may occur. [1]
A stye, also known as a hordeolum, is a bacterial infection of an oil gland in the eyelid. [4] This results in a red tender bump at the edge of the eyelid. [1] [5] The outside or the inside of the eyelid can be affected. [3] The cause of a stye is usually a bacterial infection by Staphylococcus aureus.
Thelaziasis is the term for infestation with parasitic nematodes of the genus Thelazia.The adults of all Thelazia species discovered so far inhabit the eyes and associated tissues (such as eyelids, tear ducts, etc.) of various mammal and bird hosts, including humans. [2]
Eyelid dermatitis is the inflammation of the eyelid skin. It is mostly a result of allergies or contact dermatitis of the eyelid. Symptoms include dry and flaky skin on the eyelids and swollen eyelids. The affected eyelid may itch. Treatment consists in proper eye hygiene and avoiding the allergens that trigger the condition.
The 5% treatment also caused less irritation compared to 10% minoxidil. It’s not all bad news for the higher strengths, though. If 5% minoxidil doesn’t kick your hair follicles into shape, the ...
Seborrhoeic dermatitis can look similar to other skin conditions that share its characteristic dry, flaky, scaly, and inflamed appearance but have different causes and treatments. Physicians use the history of the individual with the skin condition as well as other tests to identify which disorder is present.
Trachoma is an infectious disease caused by bacterium Chlamydia trachomatis. [2] The infection causes a roughening of the inner surface of the eyelids. [2] This roughening can lead to pain in the eyes, breakdown of the outer surface or cornea of the eyes, and eventual blindness. [2]
From January 2008 to April 2010, if you bought shares in companies when William F. Aldinger III joined the board, and sold them when he left, you would have a -37.2 percent return on your investment, compared to a -19.2 percent return from the S&P 500.